The Cancer Proteome Atlas (TCPA, LIHC cohort) database [23,24] revealed that ~46% of the investigated HCC patients (n = 82/179) displayed enhanced CCNE1 protein levels above mean (Figure S6a,b). This evidence concerns the gene CCNE1 and hepatocellular carcinoma.